Hi loki01 and Discocopper,IMO! Hopefully the company will find a way to return monies as a capital return {with the significant tax advantages that implies { I hope}} as CHZ would certainly have spent more on Kestanelik than they are returning to share holders. As with most juniors this one follows the same pattern, a depressing negative return on the exploration dollar! Par for the course, more so in a prolonged bear market. Discocopper: IMO Sisorta and Catak are negative assets, why spend more time on them unless , maybe the hierarchy think that they can justify prolonging the gravy train for a few more years. [Just joking, I'm sure they will do their best for all CHZ shareholders.] I just won't be one of them! For every dollar spent on the third rate targets the return won't be even 10% IMO. BOLTA!
CHZ Price at posting:
17.0¢ Sentiment: Hold Disclosure: Held